Accumulation of the amyloid beta peptide (Aβ) in the cortical and hippocampal regions of the brain is a major pathological feature of Alzheimer's disease (AD). Aβ is generated from the sequential protease cleavage of the amyloid precursor protein (APP). We previously reported that copper increases the level of APP at the cell surface. Here we report that copper, but not iron or zinc, promotes APP trafficking in cultured polarised epithelial cells and neuronal cells. In SH-SY5Y neuronal cells and primary cortical neurons, copper promoted a redistribution of APP from a perinuclear localisation to a wider distribution including neurites. Importantly, a change in APP localisation was not attributed to an upregulation of APP protein synthesis. Using live cell imaging and endocytosis assays we found that copper promotes an increase in cell surface APP-by increasing its exocytosis and reducing its endocytosis respectively. This study identifies a novel mechanism by which copper regulates the localisation and presumably, function of APP, which is of major significance for understanding the role of APP in copper homeostasis and the role of copper in Alzheimer's disease.
results in both animal and human trials (23) (24) (25) (26) . A proposed mechanism of action of these drugs is to bind to extracellular copper and restore intracellular copper levels, hence correcting copper dyshomeostasis.
Importantly, these ionophores are capable of reducing amyloid load and attenuate cognitive decline (23) (24) (25) (26) .
Amyloid precursor protein (APP) is differentially processed by the α-, β-and γsecretases in two alternative processing pathways, commonly referred to as the non-amyloidogenic and amyloidogenic pathways ( Fig. S1 ). In the non-amyloidogenic pathway, APP is initially cleaved by an α -secretase that is predominantly localised to the plasma membrane (27, 28) , Copper has been shown to modulate APP metabolism. An increase in intracellular copper levels promotes the non-amyloidogenic pathway (31, 32) . In addition, copper regulates APP expression, whereby a decrease in intracellular copper downregulates APP gene expression (33) .
Conversely, elevated cellular copper levels result in upregulation of APP gene expression (34) .. Importantly, APP is proposed to participate in copper homeostasis via a role in the copper efflux pathway (35, 36) . Overexpression of APP in cultured cell and animal models leads to decreased cellular copper levels (35, 37, 38) . We recently reported that copper promotes an increase in the level of APP at the cell surface in SH-SY5Y human neuroblastoma cells with a reduction in lipid raft mediated APP processing (39) .
In the current study, we investigated the effect of copper on APP cellular localisation and the dynamics of changes in its localisation. We report that in both neuronal and non-neuronal cell models, APP traffics from the Golgi to intracellular compartments and to the cell surface in response to increases in intracellular copper, but not zinc or iron. We provide evidence that this is due to an increase in the rate of APP exocytosis with a concomitant reduction in its rate of endocytosis.
Material and Methods

Antibodies and reagents
The following antibodies were used in this study:
GM-130 (BD Transduction laboratories), golgin-97 (Invitrogen); CT20 (C-terminal APP antibody, Calbiochem); β-Actin (Sigma); W0-2 (40); 22C11 (41) . The antibody CT77 was used to detect the copper transporter ATP7A and was a kind gift from Prof. B. Eipper from the University of Connecticut, Neuroscience and Molecular, Microbial and Structural Biology division (42, 43) .
The APP antibodies W0-2, 22C11 and CT20 all recognise full-length APP. The W0-2 antibody also specifically recognises the human Aβ sequence and sAPP-α, whilst the CT20 antibody specifically recognises residues 751-770 and will detect C-terminal fragments cleaved by α-, β-and 
Western blot analysis
Proteins in cell lysates were separated by SDS- 
Analysis of APP processing
To analyse the level of secreted APP processing products, including sAPP-α, -β and Aβ, conditioned media was collected. Protein in 400 µl of conditioned media was precipitated using 5
volumes of ice-cold 10% trichloroacetic acid, as previously described (48) . Protein was pelleted by centrifugation at 10,000 × g for 30 minutes and resuspended in 50 µl of sample loading buffer (Novex Tricine SDS sample buffer, Invitrogen).
The level of sAPPα in conditioned media from three independent experiments was evaluated by densitometry whereby pixel intensities (arbitrary unit) were quantified using the Multi Gauge software (Fuji) and normalised relative to total APP detected in the cell lysate.
Cell surface biotinylation
Cell surface biotinylation to isolate cell surface proteins was performed as previously described (45, 49) . Briefly, SH-SY5Y cells were treated with 
Densitometry analysis
The level of APP and APP processing products from three independent experiments was evaluated by densitometry whereby pixel intensities (arbitrary unit) were quantified using the Multi Gauge software (Fuji) and normalised relative to total APP detected in the cell lysate.
Antibody uptake (endocytosis) assays
APP endocytosis assays have been described previously (50, 51) . Briefly, SH-SY5Y cells plated on coverslips were washed in ice-cold PCM buffer This experiment was repeated three times.
In each experiment, between 40 and 60 cells were scored for undergoing APP endocytosis. The rate of endocytosis was represented as the average percentage of cells undergoing endocytosis per time point and treatment, as described previously (50, 51) . Statistical analysis was carried out using the Student T-test.
Results
Copper-stimulated relocalisation of APP in cultured neuronal and polarised epithelial cells.
We previously reported that in the human neuroblastoma SH-SY5Y cell line, an increase in copper concentration stimulated an increase in the level of APP at the cell surface (39) . In the present study, we further investigated the influence of copper on APP trafficking in both neuronal and polarised epithelial cell models using confocal fluorescence imaging techniques. Experiments were carried out in normal growth media and the concentration of copper used was based on our previous studies (32, 45, 46) . Consistent with our previous finding ( have been widely used to study APP cellular localisation and processing (53) . Under copper deficient conditions, APP-cherry demonstrates a perinuclear localisation ( Fig. 1 ). However, exposure to 150 µM copper or greater led to a dispersed localisation of APP-cherry throughout the cytoplasm (Fig. 1 ). APP-cherry also redistributed at lower copper concentrations (25 µM)
after a longer period of incubation (12 hrs;
Supplemental Figure S3 ). This is consistent with lower rates of copper uptake at lower extracellular copper concentrations.
In To ensure that the observed copperresponsive change in APP-cherry localisation was specific to APP, we used the monoclonal antibody W0-2 to immunolabel APP. There was strong colocalisation of APP-cherry with W0-2 under the differential copper conditions tested in this study (Supplemental Fig. S5 ).
Copper-responsive APP trafficking is not due to upregulation of APP expression. We previously discovered copperresponsive trafficking of ATP7A, an essential copper transporting P-type ATPase, from the Golgi to the plasma membrane to mediate cellular copper export (45, 49, 59) . To determine whether copper-responsive trafficking of APP utilises a similar exocytic pathway to that of ATP7A, we compared the cellular localisation of APP and ATP7A under differential copper conditions. In the presence of copper chelators, endogenous APP and ATP7A partially co-localised primarily to the Golgi ( Figure 4A ). Following copper treatment, both APP and ATP7A demonstrated a wider distribution throughout the cytoplasm ( Figure 4B ).
However, there was no observable co-localisation between APP and ATP7A, suggesting that these proteins traffic via different exocytic pathways. 
Similar to SH-SY5Y cells, endogenous
Discussion
In this study we discovered a novel process (66)). In this study we show that similar to insulinstimulated GLUT4 trafficking properties, copperresponsive cell surface relocalisation of APP results from a concomitant increase in exocytosis and reduced endocytosis. This relates to a potential role for APP in the copper efflux pathway (32, 33, 38) .
We previously reported increased copper efflux following the Cu-responsive trafficking of ATP7A from the Golgi network to the PM (42, 67) .
An increase in APP at the PM may be influencing copper efflux as occurs for the copper transporter ATP7A when at the PM or in rapid recycling compartments proximal to the PM (49) . Copperresponsive trafficking of APP is therefore consistent with a role for APP in copper efflux pathways (38) . Indeed various studies have reported an interdependent relationship between APP expression and copper levels, implicating an important role for APP in copper homeostasis. For instance, over-expression of APP in primary cortical neurons resulted in decreased intracellular copper levels (38) . Increases in APP at the PM may also lead to modulation of signalling processes mediated by APP (68) (69) (70) .
It has been reported that exposure to copper decreases Aβ levels (31, 32, 39, 71, 72) .
Under conditions used in this study, we did not observe any detectable changes in APP processing. Fig. 1 . APP-cherry traffics in response to copper in polarised epithelial cells. Madin Darby Canine Kidney (MDCK) cells stably expressing APP with a C-terminal fluorescent tag ("cherry") were incubated with copper-chelators (bathocuproine disulfonate (BCS) and D-penicillamine (D-Pen) (150 µM; i) or increasing levels of copper (50, 150 or 200 µM; ii-iv) for 3 hours. At this time interval and at copper concentrations of 150 µM and above, APP-cherry re-distributes from a perinuclear localisation to a wider distribution throughout the cell as detected by imaging using confocal microscopy. Scale bar = 5 µM. Fig. 2 . The co-localisation of APP and early endosomal marker EEA1 increases following copper treatment. MDCK-APP-cherry were incubated with either copper chelators (-Cu; BCS and D-Pen) or copper (+Cu; 150 µM) followed by immunolabelling with the W0-2 and EEA1 antibodies to detect APP and early endosomes, respectively. Under copper deficient conditions (-Cu; top panel) APP shows a partial co-localisation with EEA1, which increases following treatment with copper (+Cu; bottom panel). The nucleus was visualised by using DAPI stain. Scale bar= 5 µm.
FIGURE LEGENDS
Fig. 3. APP exits the Golgi in response to elevated intracellular copper in SH-SY5Y cells.
SH-SY5Y cells were treated with copper-chelators (BCS and D-Pen; 150 µM) (A) or copper (150 µM) (B) for 3 hr. Following fixation steps, cells were immunolabelled with antibodies against APP (W0-2) and GM130, a cis-Golgi marker. The degree of co-localisation between GM130 and APP was analysed using Pearson's correlation coefficient (r p ). Under copper deficient conditions, the average Pearson's correlation coefficient was calculated to be 0.733 (S.D. = 0.0321), in comparison to 0.564 (S.D. = 0.111) following copper treatment. DAPI stain (left panels) was used to visualise the nucleus. White arrows indicate the localisation of APP following chelator or copper incubation. Scale bar = 10 µM. Fig. 4 . APP and the copper-transporter, ATP7A, exhibit copper responsive trafficking in SH-SY5Y. SH-SY5Y cells were treated with (A) 150µM copper-chelators or (B) 150 µM copper as previously described. Cells were immunolabelled to detect APP and ATP7A using W0-2 and CT77 antibodies respectively. DAPI stain (left panels) was used to visualise the nucleus. Under copper deficient conditions both APP and ATP7A show perinuclear localisation. APP and ATP7A redistribute following copper treatment to differential subcellular compartments. White arrows indicate the localisation of APP or ATP7A following chelator or copper incubation. Scale bar = 10 µm.
Fig. 5. APP and ATP7A exhibit copper responsive trafficking in primary cortical neurons.
Primary cortical neurons isolated from E14 embryos were exposed to either copper-chelators (i) or increasing levels of copper (5, 10, and 20 µM; ii-iv) for 3 hours in neurobasal media (described in Materials and Methods). Cells were immunolabelled for APP using the CT20 antibody. Upon addition of 5 µM copper and above, APP re-localises from a predominant perinuclear location to neurites, as indicated by the white arrows. (B) Similarly, in the presence of copper-chelators (i) ATP7A demonstrates a perinuclear localisation and re-distributes to neurites upon addition of copper (10 µM). Scale bar = 10 µm. Fig. 6 . Copper does not affect the levels of sAPPα and sAPPβ in conditioned media. SH-SY5Y cells were incubated with either copper-chelators (-Cu; 150 µM) or copper (+Cu; 150 µM). The 22C11 antibody was used to detect full-length APP in cell lysates and the proteolytic product sAPPα/sAPPβ in the growth medium. Arrows indicate bands corresponding to sAPPα and sAPPβ in conditioned medium. β-actin was used as a loading control. (B) The level of sAPPα and sAPPβ following copper-chelator or copper treatment was analysed by densitometry. There was no statistically significant difference between the levels of sAPPα/β and chelator/copper treatment (n=3, p>0.1). Fig. 7 . Real-time imaging of copper-stimulated APP trafficking. MDCK-APP-cherry cells cultured on 40 mm coverslips were incubated in BME medium without phenol red supplemented with 2% fetal calf serum (described in Materials and Methods) and above media supplemented with copper (150 µM). Images were captured under basal conditions (00:00) and following the addition of copper at 2 minute intervals for approximately 25 minutes using an Olympus FV1000 laser scanning confocal microscope (see supplemental Fig. S8 ). Panels represent a series of images acquired at five different time points following the addition of copper. Numbers at the top left hand corner indicate the minutes and seconds (min:sec) following the addition of copper. Scale bar = 5 µm. . APP structure and processing. APP is an integral transmembrane (TM) protein that can be processed by two alternative processing pathways. (A) Non-amyloidogenic pathway. APP is cleaved by α-and γ-secretases to release the extracellular ectodomain (sAPPα), a non-toxic 3 kDa peptide (p3) and the APP intracellular domain (AICD). (B) Amyloidogenic pathway. APP is cleaved by β-and γ-secretases to release the toxic β-amyloid (Aβ) peptide, ectodomain (sAPPβ) and the AICD fragment. APP contains two copper binding sites located at the N-terminus (residues 135-175) and within the Aβ sequence (H6, H13 and H14). A zinc-binding site has also been identified at the Nterminus (residues 181-188).
Fig. S2. Copper promotes an increase in the level of cell surface APP in SH-SY5Y. (A)
To label proteins at the cell surface, SH-SY5Y cells were incubated with NHS-SS-Biotin following copper (150µM) or copper-chelator (150 µM) treatment (3 hrs) (as previously described in (38, 42) ). Biotinylated proteins were analysed by western blot and APP detected using the W0-2 antibody. The molecular weight (kDa), as determined using protein standards, is indicated in the left hand side of the panels. Black arrows indicate the glycosylated forms of APP present in the total cell lysate. This western blot is representative of three independent experiments. (B) Following densitometry analysis, the level of cell surface APP was compared to that of intracellular total APP in cell lysates. As represented in the graph, there is an approximate 2-fold increase of cell surface APP following copper treatment in comparison to copper-chelator treatment (n=3, P=0.009).
Fig. S3. Trafficking of APP is observed at lower copper concentrations for a longer incubation time.
MDCK-APP-cherry cells were incubated with media supplemented with either 50 µM copperchelators (i) or with 25 µM copper (ii) for approximately 12 hours. Scale bar = 5 µm.
Fig. S4. APP traffics in response to increases in copper (Cu) levels but not iron (Fe) or zinc (Zn).
MDCK-APP-cherry stable cells were incubated in growth medium supplemented with 150 µM of copper (CuCl 2 ), iron (FeCl3) or zinc (ZnSO 4 ) for 3 hours. The cellular localisation of APP-cherry following metal treatment was compared to its localisation under basal conditions. Scale bar = 5 µm. S5 . The APP monoclonal antibody (W0-2) recognises APP-cherry following copper or copper-chelator treatment. APP antibody W0-2 was used to detect APP in APP-cherry transfected MDCK cells following chelator (-Cu) or copper (+Cu; 150 µM) treatment. The W0-2 antibody confirmed the re-distribution of APP-cherry following increases in intracellular copper is APP specific. Scale bar =5 µm.
Fig.
Fig. S6
. Copper-responsive APP trafficking is not due to an increase in copper-mediated upregulation of APP expression. (A) SH-SY5Y cells were incubated in growth media supplemented with either copper-chelators (i) or copper (ii) for 3 hr. The level of APP following these treatments was measured by western blot analysis. The level of actin was analysed as a loading control. (B) SH-SY5Ycells were treated with growth media supplemented with copper-chelators (-Cu) or copper (+Cu; 150 µM) in the presence of 50 µg/ml cycloheximide, a protein synthesis inhibitor. Following 3 hr of incubation, the localisation of endogenous APP was investigated by immunofluorescence and confocal microscopy. Scale bar =10 µm.
Fig. S7
. Schematic diagram of APP antibody epitopes and secretase cleavage sites. APP antibodies used in this study are shown in bold and recognition sites indicated by parentheses. The αsecretase (cleaves after M671), β-secretase (cleaves after K687) and γ-secretase (cleaves after either V7111 or A713) cleavage sites are also indicated. Residues in blue correspond to the Aβ(42) sequence. Histidine residues involved in copper binding are highlighted in red.
Fig. S8. Live cell imaging of copper-stimulated APP-cherry exocytosis in MDCK cells.
MDCK cells stably expressing APP-cherry grown on coverslips were mounted to a "bioptics" live cell 
